WILLIAM H. RASTETTER - 30 Apr 2025 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role
Director
Signature
Christopher Aker, Attorney in Fact
Issuer symbol
RGLS
Transactions as of
30 Apr 2025
Net transactions value
$0
Form type
4
Filing time
30 Apr 2025, 16:30:05 UTC
Previous filing
16 Aug 2024
Next filing
07 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Award $0 +62,500 +160% $0.000000 101,556 30 Apr 2025 The Rastetter Family Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 30, 2025, the Reporting Person was granted 62,500 Restricted Stock Units (the "Award"). The Award vests in equal monthly installments over the 12 months from the date of grant.